Cargando…
Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
BACKGROUND: Chronic lymphocytic leukemia (CLL) has been a good model system to understand the functional role of 5-methylcytosine (5-mC) in cancer progression. More recently, an oxidized form of 5-mC, 5-hydroxymethylcytosine (5-hmC) has gained lot of attention as a regulatory epigenetic modification...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322269/ https://www.ncbi.nlm.nih.gov/pubmed/30616658 http://dx.doi.org/10.1186/s13072-018-0252-7 |
_version_ | 1783385586677055488 |
---|---|
author | Wernig-Zorc, Sara Yadav, Mukesh Pratap Kopparapu, Pradeep Kumar Bemark, Mats Kristjansdottir, Hallgerdur Lind Andersson, Per-Ola Kanduri, Chandrasekhar Kanduri, Meena |
author_facet | Wernig-Zorc, Sara Yadav, Mukesh Pratap Kopparapu, Pradeep Kumar Bemark, Mats Kristjansdottir, Hallgerdur Lind Andersson, Per-Ola Kanduri, Chandrasekhar Kanduri, Meena |
author_sort | Wernig-Zorc, Sara |
collection | PubMed |
description | BACKGROUND: Chronic lymphocytic leukemia (CLL) has been a good model system to understand the functional role of 5-methylcytosine (5-mC) in cancer progression. More recently, an oxidized form of 5-mC, 5-hydroxymethylcytosine (5-hmC) has gained lot of attention as a regulatory epigenetic modification with prognostic and diagnostic implications for several cancers. However, there is no global study exploring the role of 5-hydroxymethylcytosine (5-hmC) levels in CLL. Herein, using mass spectrometry and hMeDIP-sequencing, we analysed the dynamics of 5-hmC during B cell maturation and CLL pathogenesis. RESULTS: We show that naïve B-cells had higher levels of 5-hmC and 5-mC compared to non-class switched and class-switched memory B-cells. We found a significant decrease in global 5-mC levels in CLL patients (n = 15) compared to naïve and memory B cells, with no changes detected between the CLL prognostic groups. On the other hand, global 5-hmC levels of CLL patients were similar to memory B cells and reduced compared to naïve B cells. Interestingly, 5-hmC levels were increased at regulatory regions such as gene-body, CpG island shores and shelves and 5-hmC distribution over the gene-body positively correlated with degree of transcriptional activity. Importantly, CLL samples showed aberrant 5-hmC and 5-mC pattern over gene-body compared to well-defined patterns in normal B-cells. Integrated analysis of 5-hmC and RNA-sequencing from CLL datasets identified three novel oncogenic drivers that could have potential roles in CLL development and progression. CONCLUSIONS: Thus, our study suggests that the global loss of 5-hmC, accompanied by its significant increase at the gene regulatory regions, constitute a novel hallmark of CLL pathogenesis. Our combined analysis of 5-mC and 5-hmC sequencing provided insights into the potential role of 5-hmC in modulating gene expression changes during CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13072-018-0252-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6322269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63222692019-01-09 Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia Wernig-Zorc, Sara Yadav, Mukesh Pratap Kopparapu, Pradeep Kumar Bemark, Mats Kristjansdottir, Hallgerdur Lind Andersson, Per-Ola Kanduri, Chandrasekhar Kanduri, Meena Epigenetics Chromatin Research BACKGROUND: Chronic lymphocytic leukemia (CLL) has been a good model system to understand the functional role of 5-methylcytosine (5-mC) in cancer progression. More recently, an oxidized form of 5-mC, 5-hydroxymethylcytosine (5-hmC) has gained lot of attention as a regulatory epigenetic modification with prognostic and diagnostic implications for several cancers. However, there is no global study exploring the role of 5-hydroxymethylcytosine (5-hmC) levels in CLL. Herein, using mass spectrometry and hMeDIP-sequencing, we analysed the dynamics of 5-hmC during B cell maturation and CLL pathogenesis. RESULTS: We show that naïve B-cells had higher levels of 5-hmC and 5-mC compared to non-class switched and class-switched memory B-cells. We found a significant decrease in global 5-mC levels in CLL patients (n = 15) compared to naïve and memory B cells, with no changes detected between the CLL prognostic groups. On the other hand, global 5-hmC levels of CLL patients were similar to memory B cells and reduced compared to naïve B cells. Interestingly, 5-hmC levels were increased at regulatory regions such as gene-body, CpG island shores and shelves and 5-hmC distribution over the gene-body positively correlated with degree of transcriptional activity. Importantly, CLL samples showed aberrant 5-hmC and 5-mC pattern over gene-body compared to well-defined patterns in normal B-cells. Integrated analysis of 5-hmC and RNA-sequencing from CLL datasets identified three novel oncogenic drivers that could have potential roles in CLL development and progression. CONCLUSIONS: Thus, our study suggests that the global loss of 5-hmC, accompanied by its significant increase at the gene regulatory regions, constitute a novel hallmark of CLL pathogenesis. Our combined analysis of 5-mC and 5-hmC sequencing provided insights into the potential role of 5-hmC in modulating gene expression changes during CLL pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13072-018-0252-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-07 /pmc/articles/PMC6322269/ /pubmed/30616658 http://dx.doi.org/10.1186/s13072-018-0252-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Wernig-Zorc, Sara Yadav, Mukesh Pratap Kopparapu, Pradeep Kumar Bemark, Mats Kristjansdottir, Hallgerdur Lind Andersson, Per-Ola Kanduri, Chandrasekhar Kanduri, Meena Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia |
title | Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia |
title_full | Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia |
title_fullStr | Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia |
title_full_unstemmed | Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia |
title_short | Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia |
title_sort | global distribution of dna hydroxymethylation and dna methylation in chronic lymphocytic leukemia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322269/ https://www.ncbi.nlm.nih.gov/pubmed/30616658 http://dx.doi.org/10.1186/s13072-018-0252-7 |
work_keys_str_mv | AT wernigzorcsara globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia AT yadavmukeshpratap globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia AT kopparapupradeepkumar globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia AT bemarkmats globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia AT kristjansdottirhallgerdurlind globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia AT anderssonperola globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia AT kandurichandrasekhar globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia AT kandurimeena globaldistributionofdnahydroxymethylationanddnamethylationinchroniclymphocyticleukemia |